A slow-release dexamethasone implant for cancer-associated retinopathy

ABSTRACT This case report aims to show the anatomical and functional results of a patient diagnosed as having cancer-associated retinopathy treated with a controlled-release dexamethasone implant (Ozurdex). Anatomical outcomes were assessed using spectral domain optical coherence tomography; and functional outcomes, by measuring visual acuity, microperimetry, and mutifocal electroretinography. The follow-up period was 1 year.摘要：本病例报告旨在呈现1例确诊为癌症相关性视网膜病变（cancer-associated retinopathy）患者接受地塞米松缓释植入剂（Ozurdex）治疗后的解剖学与功能学结局。解剖学结局采用光谱域光学相干断层扫描（spectral domain optical coherence tomography）进行评估；功能学结局则通过检测视力、微视野检查及多焦视网膜电图（multifocal electroretinography）予以评定。本次随访周期为1年。